pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 29·1 min read
save

Trump administration proposes overhaul of federal grant rules, sparking researcher concerns

May 29, 2026·read at STAT ↗RegulatoryNegative

The White House released a more than 400-page proposal that would rewrite the core regulation governing all federal grants. The administration says the changes are meant to curb waste and increase oversight.

The draft would shift emphasis away from peer review when deciding which projects receive funding, restrict scientists' ability to use federal money for publishing papers or attending conferences, and give political appointees broader authority to end grants at their discretion.

Researchers expressed alarm, warning that the moves could undermine the independence of scientific inquiry and slow progress in biomedical research. If adopted, the policy would apply across government agencies, potentially reshaping the funding landscape for pharma and biotech development.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Trump administration seeks to overhaul federal grantmaking process, alarming researchers”

read at STAT ↗
471 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Obesity
topics
Obesity

related stories

  • Apr 30STAT+: FDA wants to exclude weight loss drugs from a compounding listSTAT
  • Apr 30Smog from wildfires increasingly harmful, data showSTAT
  • Apr 30Updated: Early sales of Lilly’s obesity pill appear to trail Novo’sEndpoints
  • Apr 30STAT+: New obesity tool aims to predict risk of 18 serious complicationsSTAT
  • Apr 29STAT+: A patent win for Pfizer and BridgeBioSTAT